Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat

  • T. Kling-Petersen
  • E. Ljung
  • L. Wollter
  • K. Svensson
Full Papers

Summary

Compounds showing an in vitro binding preference for the dopamine D3 receptor were tested in two models designed to assess positive reinforcement in the rat: intracranial self-stimulation (ICSS) and conditioned place preference (CPP). R-(+)-7-OH-DPAT, a D3 preferring agonist, inhibited ICSS behaviour over a wide dose range. At higher doses, a facilitation of ICSS was seen. In the CPP model, 7-OH-DPAT was inactive except at the highest dose where a significant change in preference was seen. A dose of R-(+)-7-OH-DPAT, that significantly inhibited ICSS behaviour, was combined with a dose of d-amphetamine, that significantly facilitated ICSS behaviour. Surprisingly, this resulted in a significant synergistic facilitation of the amphetamine response. The putative D3 antagonist, U99194A was inactive in the ICSS model but induced significant place preference.

The present results suggest that the dopamine D3 receptor, in contrast to the D2 receptor, has an inhibitory influence on reward mechanisms.

Keywords

D3 receptor conditioned place preference intracranial self-stimulation 7-OH-DPAT (+)-3PPP rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bloom FE, Young WG, Kim YM (1990) Brain browser. Academic Press, San Diego, p 220Google Scholar
  2. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564: 203–219PubMedGoogle Scholar
  3. Bozarth MA, Reid LD (1977) Addictive agents and intracranial stimulation (ICS): naloxone blocks morphine's acceleration of pressing for ICS. Bull Psych Soc 10: 478–480Google Scholar
  4. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D3 dopamine receptors. Science 260: 1814–1816PubMedGoogle Scholar
  5. Carr GD, White NM (1983) Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci 33: 2551–2557PubMedGoogle Scholar
  6. Carr GD, White NM (1986) Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study. Psychopharmacology 89: 340–346PubMedGoogle Scholar
  7. Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 264–319Google Scholar
  8. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Tol HHM (1991) Molecular biology of the dopamine receptor. Eur J Pharmacol 207: 277–286PubMedGoogle Scholar
  9. Colle LM, Wise RA (1991) Circling induced intra-accumbens amphetamine injections. Psychopharmacology (Berl) 105: 157–161Google Scholar
  10. Daly SA, Waddington JL (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other “D-2-like” agonists. Neuropharmacology 32: 509–510PubMedGoogle Scholar
  11. Damsma G, Bottema T, Westerink BHC, Tepper PG, Dijkstra D, Pugsley TA, MacKenzie RG, Heffner TG, Wikström H (1993) Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur J Pharmacol 249: R9-R10PubMedGoogle Scholar
  12. Dreher JK, Jackson DM (1989) Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens. Brain Res 487: 267–277PubMedGoogle Scholar
  13. Essman WD, McGonigle P, Lucki I (1993) Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology 112: 233–241PubMedGoogle Scholar
  14. Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-E, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 81: 89–99PubMedGoogle Scholar
  15. Kling-Petersen T, Svensson K (1992) Effects of the preferential dopamine autoreceptor antagonist (+)-AJ76 in the intracranial self-stimulation paradigm. Pharmacol Biochem Behav 43: 495–501PubMedGoogle Scholar
  16. Kling-Petersen T, Svensson K (1993) A simple computer based method for performing and analysing intracranial self-stimulation experiments in rats. J Neurosci Methods 47: 215–225PubMedGoogle Scholar
  17. Kling-Petersen T, Ljung E, Svensson K (1994a) The preferential dopamine autoreceptor antagonist, (+)-UH232, antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacol Biochem Behav 49: 345–351PubMedGoogle Scholar
  18. Kling-Petersen T, Ljung E, Wollter L, Svensson K (1994b) Behavioural effects of the dopamine D3- and autoreceptor preffering antagonist, (−)-DS121, on locomotor activity and in the conditioned place preference and intracranial self-stimulation paradigms. Behav Pharmacol (in press)Google Scholar
  19. Koob GF (1992) Dopamine, addiction and reward. The Neurosciences 4: 139–148Google Scholar
  20. Leith NJ (1983) Effects of apomorphine on self-stimulation responding: does the drug mimic the current? Brain Res 277: 129–136PubMedGoogle Scholar
  21. Lévesque D, Diaz J, Pilon C, Martres M-P, Giros B, Souil E, Schott D, Morgat J-L, Schwartz J-C, Sokoloff P (1992) Identification, characterization and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetraline. Proc Natl Acad Sci 89: 8155–8159PubMedGoogle Scholar
  22. Litchfleld JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113Google Scholar
  23. Meller E, Bohmaker K, Goldstein M, Bashman DA (1993) Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors. Eur J Pharmacol 249: R5-R6PubMedGoogle Scholar
  24. Nakajima S, O'Regan NB (1991) The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat. Pharmacol Biochem Behav 39: 465–468PubMedGoogle Scholar
  25. Phillips AG, Fibiger HC (1989) Neuroanatomical bases of intracranial self-stimulation: untangling the Gordian knot. In: Liebman JM, Cooper SJ (eds) The pharmacological basis of reward. Oxford University Press, Oxford, pp 66–105Google Scholar
  26. Radhakishun FS, van Ree JM (1987) The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur J Pharmacol 136: 41–47Google Scholar
  27. Richardson NR, Piercey MF, Svensson K, Collins RJ, Myers JE, Roberts DCS (1993) Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ76. Brain Res 619: 15–21PubMedGoogle Scholar
  28. Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146–151PubMedGoogle Scholar
  29. Sonesson C, Waters N, Svensson K, Carlsson A, Smith MW, Piercey PF, Meier E, Wikström H (1993) Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonists. J Med Chem 36: 3188–3195PubMedGoogle Scholar
  30. Spyraki C, Fibiger HC, Phillips AG (1982a) Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253: 195–203PubMedGoogle Scholar
  31. Spyraki C, Fibiger HC, Phillips AG (1982b) Dopaminergic substrates of amphetamineinduced place preference conditioning. Brain Res 253: 185–193PubMedGoogle Scholar
  32. Stellar JR, Rice MB (1989) Pharmacological basis of intracranial self-stimulation reward. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 16–65Google Scholar
  33. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HHM, Niznik HB (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350: 614–619PubMedGoogle Scholar
  34. Svensson K, Thorngren M, Wollter L, Carlsson A (1991) The dopamine (D3 prefering) autoreceptor antagonists (+)-AJ76 and (+)-UH232 produce conditioned place preference in the rat. Soc Neurosci Abstr 17: 1352Google Scholar
  35. Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N (1994a) Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 263: 235–243PubMedGoogle Scholar
  36. Svensson K, Carlsson A, Waters N (1994b) Locomotor inhibition by the D3 ligand R-(+)- 7-OH-DPAT is independent of changes in dopamine release. J Neural Transm [GenSect] 95: 71–74Google Scholar
  37. Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A (1993) The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm [GenSect] 94: 11–19Google Scholar
  38. White NM, Packard MG, Hiroi N (1991) Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens. Psychopharmacology (Berl) 103: 271–276Google Scholar
  39. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40: 191–225PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • T. Kling-Petersen
    • 1
  • E. Ljung
    • 1
  • L. Wollter
    • 1
  • K. Svensson
    • 1
  1. 1.Department of PharmacologyUniversity of GöteborgSweden
  2. 2.CNS Disease ResearchThe Upjohn CompanyKalamazooUSA

Personalised recommendations